196 related articles for article (PubMed ID: 35448545)
1. ProBDNF as an Indicator of Improvement among Women with Depressive Episodes.
Zwolińska W; Skibinska M; Słopień A; Dmitrzak-Węglarz M
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448545
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
Yoshida T; Ishikawa M; Niitsu T; Nakazato M; Watanabe H; Shiraishi T; Shiina A; Hashimoto T; Kanahara N; Hasegawa T; Enohara M; Kimura A; Iyo M; Hashimoto K
PLoS One; 2012; 7(8):e42676. PubMed ID: 22880079
[TBL] [Abstract][Full Text] [Related]
3. Analysis of blood mature BDNF and proBDNF in mood disorders with specific ELISA assays.
Lin L; Fu XY; Zhou XF; Liu D; Bobrovskaya L; Zhou L
J Psychiatr Res; 2021 Jan; 133():166-173. PubMed ID: 33341455
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis.
Yang B; Ren Q; Zhang JC; Chen QX; Hashimoto K
Transl Psychiatry; 2017 May; 7(5):e1128. PubMed ID: 28509900
[TBL] [Abstract][Full Text] [Related]
5. Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression.
Zhao G; Zhang C; Chen J; Su Y; Zhou R; Wang F; Xia W; Huang J; Wang Z; Hu Y; Cao L; Guo X; Yuan C; Wang Y; Yi Z; Lu W; Wu Y; Wu Z; Hong W; Peng D; Fang Y
Mol Neurobiol; 2017 Sep; 54(7):5573-5582. PubMed ID: 27613282
[TBL] [Abstract][Full Text] [Related]
6. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts.
Södersten K; Pålsson E; Ishima T; Funa K; Landén M; Hashimoto K; Ågren H
J Affect Disord; 2014 May; 160():1-9. PubMed ID: 24709015
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.
Hashimoto K
Psychiatry Clin Neurosci; 2010 Aug; 64(4):341-57. PubMed ID: 20653908
[TBL] [Abstract][Full Text] [Related]
8. Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.
Yoshimura R; Kishi T; Hori H; Atake K; Katsuki A; Nakano-Umene W; Ikenouchi-Sugita A; Iwata N; Nakamura J
Ann Gen Psychiatry; 2014; 13():19. PubMed ID: 25089150
[TBL] [Abstract][Full Text] [Related]
9. No association of both serum pro-brain-derived neurotrophic factor (proBDNF) and BDNF concentrations with depressive state in community-dwelling elderly people.
Ohto A; Mizoguchi Y; Imamura Y; Kojima N; Yamada S; Monji A
Psychogeriatrics; 2021 Jul; 21(4):503-513. PubMed ID: 33878808
[TBL] [Abstract][Full Text] [Related]
10. Potential value of serum brain-derived neurotrophic factor, vascular endothelial growth factor, and S100B for identifying major depressive disorder in knee osteoarthritis patients.
Zhang P; Xiong Y; Wang B; Zhou Y; Wang Z; Shi J; Li C; Lu X; Chen G
Front Psychiatry; 2022; 13():1019367. PubMed ID: 36386998
[TBL] [Abstract][Full Text] [Related]
11. Role of proBDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression.
Qiao H; An SC; Xu C; Ma XM
Brain Res; 2017 May; 1663():29-37. PubMed ID: 28284898
[TBL] [Abstract][Full Text] [Related]
12. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.
Jiang H; Chen S; Li C; Lu N; Yue Y; Yin Y; Zhang Y; Zhi X; Zhang D; Yuan Y
Transl Psychiatry; 2017 Apr; 7(4):e1079. PubMed ID: 28375203
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of blood proBDNF and its receptors in major depression.
Zhou L; Xiong J; Lim Y; Ruan Y; Huang C; Zhu Y; Zhong JH; Xiao Z; Zhou XF
J Affect Disord; 2013 Sep; 150(3):776-84. PubMed ID: 23537780
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of proBDNF/p75NTR signaling in immune cells and its correlation with inflammatory markers in patients with major depression.
Yang CR; Liang R; Liu Y; Meng FJ; Zhou F; Zhang XY; Ning L; Wang ZQ; Liu S; Zhou XF
FASEB J; 2024 Jan; 38(1):e23312. PubMed ID: 38161282
[TBL] [Abstract][Full Text] [Related]
15. Plasma and Platelet Brain-Derived Neurotrophic Factor (BDNF) Levels in Bipolar Disorder Patients with Post-Traumatic Stress Disorder (PTSD) or in a Major Depressive Episode Compared to Healthy Controls.
Dell'Oste V; Palego L; Betti L; Fantasia S; Gravina D; Bordacchini A; Pedrinelli V; Giannaccini G; Carmassi C
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542503
[TBL] [Abstract][Full Text] [Related]
16. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.
Fernandes BS; Molendijk ML; Köhler CA; Soares JC; Leite CM; Machado-Vieira R; Ribeiro TL; Silva JC; Sales PM; Quevedo J; Oertel-Knöchel V; Vieta E; González-Pinto A; Berk M; Carvalho AF
BMC Med; 2015 Nov; 13():289. PubMed ID: 26621529
[TBL] [Abstract][Full Text] [Related]
17. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis.
Fernandes BS; Gama CS; Kauer-Sant'Anna M; Lobato MI; Belmonte-de-Abreu P; Kapczinski F
J Psychiatr Res; 2009 Oct; 43(15):1200-4. PubMed ID: 19501841
[TBL] [Abstract][Full Text] [Related]
18. Elevated Epidermal Growth Factor (EGF) as Candidate Biomarker of Mood Disorders-Longitudinal Study in Adolescent and Young Adult Patients.
Skibinska M; Kapelski P; Dmitrzak-Weglarz M; Lepczynska N; Pawlak J; Twarowska-Hauser J; Szczepankiewicz A; Rajewska-Rager A
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575175
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders.
Monteleone P; Serritella C; Martiadis V; Maj M
Bipolar Disord; 2008 Feb; 10(1):95-100. PubMed ID: 18199246
[TBL] [Abstract][Full Text] [Related]
20. Low BDNF levels in serum are associated with cognitive impairments in medication-naïve patients with current depressive episode in BD II and MDD.
Teng Z; Wang L; Li S; Tan Y; Qiu Y; Wu C; Jin K; Chen J; Huang J; Tang H; Xiang H; Wang B; Yuan H; Wu H
J Affect Disord; 2021 Oct; 293():90-96. PubMed ID: 34175594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
